Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia
A 3 Weeks Open Label Study to Evaluate the Efficacy in Agitation and Safety of Quetiapine Fumarate XR in Treatment of Patients With Acute Schizophrenia